Abstract. Background. Objective

Similar documents
Next-Gen Analytics in Digital Pathology

Immune Cell Phenotyping in Solid Tumors using Quantitative Pathology

Deciphering the biology that drives response to immunotherapy

Gaining New Insights Through IF Multiplexed Staining and Analysis. Tyna Hope, Ph.D. P.Eng Biomarker Imaging Research Laboratory October 5, 2017

Image analysis in IHC overview, considerations and applications

Next-Generation Immunohistochemistry: Multiplex tissue imaging with mass cytometry

Visual interpretation in pathology

Central Pathology Review and Tissue MicroArrays. Dr Lisa Storer Children s Brain Tumour Research Centre Nottingham

Final Project Report Sean Fischer CS229 Introduction

Spatially resolved multiparametric single cell analysis. Technical Journal Club 19th September 2017 Christina Müller (Group Speck)

HIGH CONTENT ANALYSIS WITH CELLULAR AND TISSUE SYSTEMS BIOLOGY: A BRIDGE BETWEEN CANCER CELL BIOLOGY AND TISSUE-BASED DIAGNOSTICS

Digital Pathology and CAP Guidelines

Does digital IHC need digital tissue controls?

Layered-IHC (L-IHC): A novel and robust approach to multiplexed immunohistochemistry So many markers and so little tissue

The following slides were presented at the TIGA Workshop, and are enclosed in the PP show format (*.pps) in order to include all presented details.

Workflow. Connecting the Pieces For Total Patient Care

OOSIGHT IVF. See what you ve been missing.

HER2 CISH pharmdx TM Kit Interpretation Guide Breast Cancer

Geisinger Clinic Annual Progress Report: 2011 Nonformula Grant

Surgical Pathology Lab of the Future. Thomas M. Grogan, M.D. Professor of Pathology, University of Arizona Founder, Ventana Medical Systems, Inc.

Incorporating pharmacodynamic, response and patient selection biomarkers. Paul Elvin PhD Chief Translational Science Officer Aptus Clinical

Supplementary Online Content

COMPUTER-AIDED HER-2/neu EVALUATION IN EXTERNAL QUALITY ASSURANCE (EQA) OF BREAST CANCER SCREENING PROGRAMME

LOCAL INFLAMMATION IN BREAST TISSUE AND MAMMOGRAPHIC DENSITY AMONG PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN

POC Brain Tumor Segmentation. vlife Use Case

Interpreting Therapeutic Response on Immune Cell Number and Spatial Distribution within the Tumor Microenvironment. Lorcan Sherry, CSO OracleBio

manifestations of disease (mostly clinical medicine)

Proteomic Biomarker Discovery in Breast Cancer

IDH1 R132H/ATRX Immunohistochemical validation

Single and Multiplex Immunohistochemistry

Optimal algorithm for HER2 testing

LC/MS/MS SOLUTIONS FOR LIPIDOMICS. Biomarker and Omics Solutions FOR DISCOVERY AND TARGETED LIPIDOMICS

Clinical evaluation of melanomas and common nevi by spectral imaging

Translating Tissue Phenomics and Big Data Distillation to Clinical Histopathology

Identification of Sickle Cells using Digital Image Processing. Academic Year Annexure I

Biomarker strategy for Personalized Healthcare at Roche

Deep learning approaches to medical applications

Welcome! HER2 TESTING DIAGNOSTIC ACCURACY 4/11/2016

Assessment performed on Friday, September 18, 2015, at Vancouver General Hospital

A New Approach For an Improved Multiple Brain Lesion Segmentation

Practical Applications of Digital Pathology

Is digital pathology ready for use in routine histopathology? Dr David Snead University Hospitals of Coventry and Warwickshire NHS Trust Coventry UK

Co-PI: Amy Trentham-Dietz, PhD

AUTOMATIC BRAIN TUMOR DETECTION AND CLASSIFICATION USING SVM CLASSIFIER

Assigning B cell Maturity in Pediatric Leukemia Gabi Fragiadakis 1, Jamie Irvine 2 1 Microbiology and Immunology, 2 Computer Science

CaPTk: Cancer Imaging Phenomics Toolkit

Dharmesh A Sarvaiya 1, Prof. Mehul Barot 2

Statistical Analysis of Hematoxylin and Eosin Stained Nuclei from Breast Cancer Tissue

Inti Zlobec 1*, Viktor H Koelzer 1,2, Heather Dawson 1,2, Aurel Perren 1,2 and Alessandro Lugli 1,2

Automatic Diagnosis of Ovarian Carcinomas via Sparse Multiresolution Tissue Representation

ARTIFICIAL INTELLIGENCE FOR DIGITAL PATHOLOGY. Kyunghyun Paeng, Co-founder and Research Scientist, Lunit Inc.

Chemical profiling for theranostics applications

Product Introduction

LN04 - Lymphoma Tissue Microarray

Androgen Receptor Expression in Renal Cell Carcinoma: A New Actionable Target?

Cancer Cells Detection using OTSU Threshold Algorithm

HER2 FISH pharmdx TM Interpretation Guide - Breast Cancer

Using CART to Mine SELDI ProteinChip Data for Biomarkers and Disease Stratification

Papillary Lesions of the breast

Application Note # MT-111 Concise Interpretation of MALDI Imaging Data by Probabilistic Latent Semantic Analysis (plsa)

Spectral Analysis of Normal and Malignant Microarray Tissue Sections Using a Novel Micro-optoelectricalmechanical System Background: Design:

EARLY STAGE DIAGNOSIS OF LUNG CANCER USING CT-SCAN IMAGES BASED ON CELLULAR LEARNING AUTOMATE

Developing quantitative slide-based assays to assess target inhibition in oncology drug discovery and development

CANCER. Clinical Validation of Breast Cancer Predictive Markers

Cleveland Clinic Laboratories Hematology Diagnostic Services. Trust in us for everything you need in a reference lab.

CC01 - Colon Cancer Tissue Microarray

Bioimaging and Functional Genomics

Untangling the tumor microenvironment

Presentation material is for education purposes only. All rights reserved URMC Radiology Page 1 of 98

Supplementary Appendix

Proceedings of the UGC Sponsored National Conference on Advanced Networking and Applications, 27 th March 2015

AUTOMATIC DIABETIC RETINOPATHY DETECTION USING GABOR FILTER WITH LOCAL ENTROPY THRESHOLDING

Carnegie Mellon University Annual Progress Report: 2011 Nonformula Grant

CINtec PLUS Cytology. Interpretation training

ANALYTISCHE STRATEGIE Tissue Imaging. Bernd Bodenmiller Institute of Molecular Life Sciences University of Zurich

A comparative study of quantitative immunohistochemistry and quantum dot immunohistochemistry for mutation carrier identification in Lynch syndrome

Quantitation of microrna 92a in colorectal adenocarcinoma and its precancerous lesions: Co utilization of in situ hybridization and spectral imaging

RSNA, /radiol Appendix E1. Methods

Augmented Medical Decisions

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

Data integration from pathology slides for quantitative imaging of multiple cell types within the tumor immune cell infiltrate

Claudin-4 Expression in Triple Negative Breast Cancer: Correlation with Androgen Receptors and Ki-67 Expression

Breast Cancer Interpretation Guide

Correlation of spectral imaging and visual grading for the quantification of thymidylate synthase protein expression in rectal cancer B

Pathology Report Patient Companion Guide

Supplemental figure 1. PDGFRα is expressed dominantly by stromal cells surrounding mammary ducts and alveoli. A) IHC staining of PDGFRα in

Immunostaining was performed on tumor biopsy samples arranged in a tissue-microarray format or on

11/8/2018 DISCLOSURES. I have NO Conflicts of Interest to Disclose. UTILTY OF DETECTING PATTERNS

Utilizing machine learning techniques to rapidly identify. MUC2 expression in colon cancer tissues

Guideline. Associated Documents ASCO CAP 2018 GUIDELINES and SUPPLEMENTS -

Assessment Run B HER2 IHC

Abbott Cell-Dyn Reticulocyte Method Comparison and Reticulocyte Normal Reference Range Evaluation

Estrogen receptor (ER)

Supplementary Information

Tissue microarray TMA

Noninvasive Blood Glucose Analysis using Near Infrared Absorption Spectroscopy. Abstract

IBCM 2, April 2009, Sarajevo, Bosnia and Herzegovina

Fluorescence Microscopy

Research Article. Automated grading of diabetic retinopathy stages in fundus images using SVM classifer

Breast Cancer Diversity Various Disease Subtypes Clinical Diversity

Transcription:

Molecular epidemiology of clinical tissues with multi-parameter IHC Poster 237 J Ruan 1, T Hope 1, J Rheinhardt 2, D Wang 2, R Levenson 1, T Nielsen 3, H Gardner 2, C Hoyt 1 1 CRi, Woburn, Massachusetts, USA, 2 Oncology Translational Laboratories, Novartis Institutes for Biomedical Research,Cambridge, Massachusetts, USA, 3 British Columbia Cancer Agency, Vancouver B.C www.cri-inc.com Seeing life in a new light.

Abstract Background A common goal in pharmaceutical research is to discover correlations between clinical outcomes and complex protein expression and interaction patterns in tissue sections. Correlations inform target validation, trial design, patient selection, response assessment, and, if trials are successful, the diagnostic component of theranostics. However, to successfully detect multiple, often weakly-expressed targets in clinical tissue sections requires appropriate staining protocols, advanced instrumentation and powerful software. Objective After developing multi-label immunohistochemical staining methods that were quantitative, independent, and specific, the goal was to create and validate an automated, whole-slide scanning imaging system that could be used to capture and distinguish multiple labels. Image analysis algorithms were used to differentiate relevant tissue regions (e.g., malignant and normal epithelia, stroma, necrosis, etc.) and segment cellular compartments (nuclei, cytoplasm, and membrane) to allow for detailed, spatially resolved multiparameter quantitation. Such as system would have an immediate application to signal-transduction research applied to conventional tissue sections. Here we describe this platform, and present results obtained from analysis of breast cancer tissue microarrays (TMAs). A key technological component of this project was multispectral imaging, which enabled the multiplexed detection. Methods and Materials Multispectral imaging, using a spectrally enabled whole-slide scanning system, was performed on two sets of a 712-core TMA (356 patients represented in duplicate). The first set was stained for ER, PR, and Her2, with a counterstain of hematoxylin, and the second stained for PR, Her1, and Her2, with a counterstain of hematoxylin. Single-stain data for comparison was obtained from previously stained and analyzed TMAs. IHC signals were spectrally unmixed and isolated from each other and the hematoxylin counterstain. Machine-learning-based automated image analysis was performed to locate cancer cells, segment subcellular compartments, and extract IHC signals on a per-cell basis. Relative stain intensities on a per-cell basis were analyzed with flowcytometry analysis software. Results and Discussion Multispectral 20x images obtained of each TMA core were acquired and spectrally unmixed at a rate of three cores per minute. Automated image analysis, using algorithms that could be developed by end-users in under 2 hours, took approximately 10 seconds per core, segmenting cancer-containing regions and extracting signals from relevant cell compartments. Concordance (r) between visual scores of single stain sections and the semi-automated scores of triple-stained samples indicate equivalency (r values ranging from 0.65 to 0.85), thus validating that multiplexed IHC faithfully reflects data obtainable with single-stains. Thus, multiplexed staining and detection, coupled with flow-cytometry analysis tools can be used to explore multiple protein expression patterns on a cell-by-cell basis, something that cannot be accomplished with serial single stains. Together, the innovative multispectral platform and software can capture cellular and subcellular expression details in an intact tissue architectural context.

An approach to utilizing multiplexed IHC in targeted drug development Explore pathway patterns with TMAs Correlate patterns with outcomes Field #5 Develop multiplexed IHC protocols 10 3 0.00% 1.69% dab 10 2 10 1 54.00% 43.74% 10 0 10 0 10 1 10 2 10 3 vector red Offer theranostic medical products Perform efficacy studies D x + R x

Multi-Parameter IHC Demonstration with ER, PR, and Her2 Step 1 : Scan TMA, Find Cores, Extract High-Power Fields (20x) RGB Image (20x) of a core

Multi-Parameter IHC Demonstration with ER, PR, and Her2 2 Step : Spectrally unmix stains from each other Spectral Library hematoxylin DAB (ER) Vector Red (Her2)

Multi-Parameter IHC Demonstration with ER, PR, and Her2 Step 3 : Classify tissue with machine learning algorithms (red = tumor, green = stroma, blue = background). Segment cellular compartments, extract spectrally unmixed signals from associated compartments, and export per-cell protein expression. Core (12,6) Core (7,7) Core (12,6) Core (7,7) Core (2,11) Core (10,3) Core (2,11) Core (10,3) Multi-parameter flow-cytometry-like outputs, but retaining tissue architecture and heterogeneity Machine learning-based automated image analysis has simple learn-by-example interface and is fast (10 20 seconds per image)

Multi-Parameter IHC Demonstration with ER, PR, and Her2 Step 4 : correlate clusters with clinical outcomes. Per-cell multi-parameter IHC Core (2,11) Core (10,3) Core (12,6) Core (7,7) 6000 4000 Her2 2000 Her2 6000 5000 4000 3000 2000 0 0 1000 2000 3000 ER 4000 Per-cell multi-parameter IHC 5000 5000 6000 6000 5000 4000 Her2 3000 2000 0 1000 2000 3000 4000 PR Per-cell multi-parameter IHC 3-D scatter plots show multi-parameter data extracted from individual cells. Note distinct clusters. Data points in the plots represent cells, and can be assessed by cluster analysis or quadrant analysis, commonly use in flow cytometry for phenotyping (double negative, single positive, double positive, etc.) 1000 1000 0 0 1000 2000 3000 4000 5000 ER 0 0 1000 2000 3000 4000 5000 6000 PR 0% 0% 11% 75% 1% 0% 16% 69% 2% 98% 1% 13% 99% 0% 3% 12% 98% 0% 0% 0% 2% 84% 0% 0% 2% 0% 8% 92% 0% 14% 0% 100%

Concordance between automated and visual scores Automated, quantitative measurements performed on spectrally unmixed stain signals were compared with visual 0-3+ and % positivity scores performed by pathologists at BCCA on single-stained serial sections of the same tissue micro-array. R-values of.80 to.90, were typical, showing equivalency ER % positivity R=0.80 Her2 0-3+ scores Visual Scores Automated Scores 0 1+ 2+ 3+ 0 554 27 5 4 1+ 13 10 1 1 2+ 3 2 11 3 3+ 1 0 5 35 R=0.85

Spectral Imaging Acquisition Images at different wavelengths Assemble the images into a data cube Spectrum at every (x,y) pixel Spectrum from nucleus with both hematoxylin and DAB Spectra of pure chromogens collected from single- stained sections Nuance TM Multispectral Imaging Systems Spectrum from membrane with just red stain Spectrum from stroma with just hematoxylin Unmixed DAB Component Unmixed Red Component RGB Representation of Spectral Cube Unmixed Hematoxylin Component Once unmixed, stains can be measured accurately.

Conclusions Multispectral imaging coupled with multiplexed IHC labeling is a practical and effective approach to detecting, isolating and quantitating low-expressing signaling pathway proteins in clinical samples CRi automated image analysis and spectral imaging enables practical multi-parameter molecular assessments of cells in intact tissue sections, thus enabling flow-on-a-slide with the added benefit of capturing critical phenotype heterogeneity across tissue sections.